国药控股(01099.HK)获摩根大通增持130.5万股

Group 1 - JPMorgan Chase & Co. increased its stake in China National Pharmaceutical Group (国药控股) by acquiring 1.305 million shares at an average price of HKD 20.8553 per share, totaling approximately HKD 27.2082 million [1] - Following this acquisition, JPMorgan's total holdings in China National Pharmaceutical Group rose to 67.38699 million shares, increasing its ownership percentage from 4.92% to 5.02% [1]